Contact information
Jenna Grabey
BA (Hons), MSc
Clinical Data Manager
I started work at the Nuffield Department of Primary Care Health Sciences in January 2018. I am the Clinical Data Manager for the INVICTUS trial, which aims to see if a novel vaccine, used in conjunction with the standard flu vaccine, offers increased protection to older adults from influenza-like illness. As well as this I work on the ARCHIE trial, also an influenza trial that investigates the early use of antibiotics in children with influenza, and the MaSC trial.
Prior to this I worked at the Medical Research Council at UCL as a Clinical Data Manager. The main trial I worked on there was CAP-IT, a trial investigating duration and dose of the antibiotic amoxicillin to treat paediatric pneumonia as well as antimicrobial resistance. I also worked on a two oncology trials in my role at the MRC CTU at UCL.
Recent publications
-
Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trial
Journal article
Freeman D. et al, (2022), Schizophrenia Research, 250, 50 - 59
-
Estimating the Economic Value of Automated Virtual Reality Cognitive Therapy for Treating Agoraphobic Avoidance in Patients With Psychosis: Findings From the gameChange Randomized Controlled Clinical Trial.
Journal article
Altunkaya J. et al, (2022), Journal of medical Internet research, 24
-
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
Journal article
Dorward J. et al, (2022), British Journal of General Practice, 72, E446 - E455
-
Quality of life, healthcare use and costs in at-risk' children after early antibiotic treatment versus placebo for influenza-like illness: Within-trial descriptive economic analyses of the ARCHIE randomised controlled trial
Journal article
Rombach I. et al, (2022), BMJ Open, 12
-
Automated virtual reality (VR) therapy (gameChange) treating agoraphobic avoidance and distress in patients with psychosis: a multicentre, parallel group, single-blind, randomised controlled trial in England with mediation and moderation analyses
Journal article
FREEMAN D. and FREEMAN D., (2022), Lancet Psychiatry